{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:30:27Z","timestamp":1768347027696,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-088946"],"award-info":[{"award-number":["DK-088946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.ackd.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T02:36:47Z","timestamp":1440383807000},"page":"404-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation"],"prefix":"10.1053","volume":"22","author":[{"given":"Pratima","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram","family":"Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2015.06.001_bib1","series-title":"Current U.S. Transplant Waiting List","year":"2014"},{"issue":"suppl 1","key":"10.1053\/j.ackd.2015.06.001_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.12581","article-title":"OPTN\/SRTR 2012 Annual Data Report: liver","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.001_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/jlts.2001.27084","article-title":"Analysis of causes of death in liver transplant recipients who survived more than 3 years","volume":"7","author":"Pruthi","year":"2001","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.001_bib4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ackd.2015.06.001_bib5","series-title":"Committee on Organ Transplantation. Assessing current policies and the potential impact of DHHS final rule","first-page":"57","article-title":"Analysis of waiting time","year":"1999"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.001_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.001_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.001_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1053\/j.gastro.2008.08.004","article-title":"Re-weighting the model for end-stage liver disease score components","volume":"135","author":"Sharma","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib9","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib10","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.001_bib12","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/TP.0b013e3182590d6b","article-title":"Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure","volume":"94","author":"Fong","year":"2012","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.001_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e318168476d","article-title":"Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts","volume":"85","author":"Locke","year":"2008","journal-title":"Transplantation"},{"key":"10.1053\/j.ackd.2015.06.001_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/lt.24189","article-title":"Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pre-transplant renal dysfunction","author":"Sharma","year":"2015","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.001_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.12557","article-title":"Revisiting multi-organ transplantation in the setting of scarcity","volume":"14","author":"Reese","year":"2014","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.001_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.22008","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","author":"Northup","year":"2010","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.001_bib19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.001_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.21367","article-title":"Transplantation: impact of pretransplant renal insufficiency","volume":"14","author":"Bahirwani","year":"2008","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1053\/j.ackd.2015.06.001_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib23","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/j.1600-6143.2011.03703.x","article-title":"Impact of MELD-based allocation on end-stage renal disease after liver transplantation","volume":"11","author":"Sharma","year":"2011","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib24","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/j.1600-6143.2012.04177.x","article-title":"Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction","volume":"12","author":"Ruebner","year":"2012","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.001_bib25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.12257","article-title":"Predicting end-stage renal disease after liver transplant","volume":"13","author":"Israni","year":"2013","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.001_bib26","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1111\/j.1600-6143.2012.04270.x","article-title":"Risk factors for end-stage kidney disease after pediatric liver transplantation","volume":"12","author":"Ruebner","year":"2012","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib27","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/TP.0b013e3181d9e195","article-title":"Risk score predicting decline in renal function postliver transplant: role in patient selection for combined liver kidney transplantation","volume":"89","author":"O'Riordan","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.001_bib28","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1681\/ASN.2013040436","article-title":"Patient-specific prediction of ESRD after liver transplantation","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.001_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ackd.2015.06.001_bib32","unstructured":"Sharma P, Perlmutter A. Renal risk index calculator,\u00a02013. rri.med.umich.edu. Accessed July 10, 2015."},{"issue":"7","key":"10.1053\/j.ackd.2015.06.001_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/lt.23867","article-title":"Intraoperative hemodialysis during liver transplantation: a decade of experience","volume":"20","author":"Nadim","year":"2014","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.001_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/lt.21682","article-title":"Acute kidney injury following liver transplantation: definition and outcome","volume":"15","author":"Barri","year":"2009","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.001_bib35","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.001_bib36","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI116440","article-title":"Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles","volume":"91","author":"Lanese","year":"1993","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.001_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.001_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.001_bib39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/lt.22292","article-title":"Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis","volume":"17","author":"Saliba","year":"2011","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.001_bib40","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2014PROTECT","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2015.06.001_bib41","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.001_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/ajt.12615","article-title":"Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation","volume":"14","author":"Sterneck","year":"2014","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/lt.500040404","article-title":"Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506)","volume":"4","author":"Canzanello","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.001_bib44","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1097\/01.tp.0000250361.60415.96","article-title":"Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up","volume":"82","author":"Moon","year":"2006","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.001_bib45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e3181d2fec1","article-title":"Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network\/United Network for Organ Sharing database","volume":"89","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.001_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-2277.2000.tb01040.x","article-title":"Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients","volume":"13","author":"Emre","year":"2000","journal-title":"Transpl Int"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.001_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.22198","article-title":"Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events","volume":"17","author":"Laish","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.001_bib48","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.tp.0000231711.82193.41","article-title":"Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant","volume":"82","author":"Roy","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.001_bib49","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1053\/j.gastro.2011.10.020","article-title":"Interferon-free treatment regimens for hepatitis C: are we there yet?","volume":"141","author":"Sharma","year":"2011","journal-title":"Gastroenterology"},{"issue":"25","key":"10.1053\/j.ackd.2015.06.001_bib50","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"issue":"9935","key":"10.1053\/j.ackd.2015.06.001_bib51","first-page":"1270","article-title":"A new direction for hepatitis C","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.001_bib52","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lt.21121","article-title":"Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence","volume":"13","author":"Sharma","year":"2007","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.001_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2006-947298","article-title":"Viral hepatitis and liver transplantation","volume":"26","author":"Sharma","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"20","key":"10.1053\/j.ackd.2015.06.001_bib54","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1053\/j.ackd.2015.06.001_bib55","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1053\/j.ackd.2015.06.001_bib56","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1053\/j.ackd.2015.06.001_bib57","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","article-title":"Sofosbuvir and ribavirin in HCV genotypes 2 and 3","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1053\/j.ackd.2015.06.001_bib58","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMc1401726","article-title":"Daclatasvir plus sofosbuvir for HCV infection","volume":"370","author":"Dhaliwal","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1053\/j.ackd.2015.06.001_bib59","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1401561","article-title":"Retreatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T03:53:25Z","timestamp":1748577205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559515000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1548559515000816"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2015.06.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}